BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7439114)

  • 1. [Edemas and myocloni concerning a patient with Parkinson's disease treated by amantadine (author's transl)].
    Chevalier JF; Renier E; Brion S
    Encephale; 1980; 6(4):381-4. PubMed ID: 7439114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effectiveness of amantadine (midantan) in the treatment of the parkinsonian syndrome].
    Kadykov AS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(2):174-8. PubMed ID: 944514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Memantine-induced myoclonus and delirium exacerbated by trimethoprim.
    Moellentin D; Picone C; Leadbetter E
    Ann Pharmacother; 2008 Mar; 42(3):443-7. PubMed ID: 18303133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of additional medication of Amantadine sulfate in L-dopa-pretreated patients with Parkinson's syndrome (author's transl)].
    Schneider E; Fischer PA; Jacobi P
    Med Klin; 1974 Mar; 69(13):541-5. PubMed ID: 4831456
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of amantadine (Viregyt-K) on extrapyramidal symptoms of parkinsonian patients.
    Boczán G
    Ther Hung; 1974; 22(4):147-53. PubMed ID: 4465958
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma amantadine concentrations in patients with Parkinson's disease.
    Nishikawa N; Nagai M; Moritoyo T; Yabe H; Nomoto M
    Parkinsonism Relat Disord; 2009 Jun; 15(5):351-3. PubMed ID: 18823813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of the parkinsonian syndrome with L-dopa and amantadine].
    Pendefunda GH; Pollingher B; Stefanache F; Gavril A; Oprişan C; Merling M; Nemţeanu E; Ciuntu M; Koropitzer I
    Neurol Psihiatr Neurochir; 1973; 18(6):559-68. PubMed ID: 4790488
    [No Abstract]   [Full Text] [Related]  

  • 8. Amantadine-induced myoclonus in a patient with progressive supranuclear palsy.
    Yarnall AJ; Burn DJ
    Age Ageing; 2012 Sep; 41(5):695-6. PubMed ID: 22421702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Modern antiparkinsonics (L-dopa and amantadine) and presentday psychiatry (author's transl)].
    Dolezalová B; Vacek J
    Cesk Psychiatr; 1976 Dec; 72(6):403-7. PubMed ID: 1000706
    [No Abstract]   [Full Text] [Related]  

  • 10. [Amantadine therapy of Parkinson's syndrome. Comment on L.W. Diehl: "Nil nocere. Adverse effects of amantadine therapy of parkinsnism"].
    Völler G
    Munch Med Wochenschr; 1972 Jun; 114(22):1066-7. PubMed ID: 5068022
    [No Abstract]   [Full Text] [Related]  

  • 11. Amantadine-induced "vocal" myoclonus.
    Pfeiffer RF
    Mov Disord; 1996 Jan; 11(1):104-6. PubMed ID: 8771080
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of intravenous administration of memantine in parkinsonian patients (author's transl)].
    Fischer PA; Jacobi P; Schneider E; Schönberger B
    Arzneimittelforschung; 1977 Jul; 27(7):1487-9. PubMed ID: 332193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ["Nil nocere." Side effects during treatment of Parkinson's disease with amantadine].
    Diehl LW
    Munch Med Wochenschr; 1972 Mar; 114(10):445-7. PubMed ID: 4625982
    [No Abstract]   [Full Text] [Related]  

  • 14. Myoclonic jerks due to acute bromovalerylurea intoxication.
    Lin JN; Lin HL; Huang CK; Lai CH; Chung HC; Liang SH; Lin HH
    Clin Toxicol (Phila); 2008 Nov; 46(9):861-3. PubMed ID: 18668386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of tolerance to the therapeutic effect of amantadine on akathisia.
    Zubenko GS; Barreira P; Lipinski JF
    J Clin Psychopharmacol; 1984 Aug; 4(4):218-20. PubMed ID: 6470196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The therapeutic effectiveness of amantadine (midantan) in parkinsonism syndromes].
    Kiseleva AM; Zlydnikov DM; Mazhinskaia VP; Lebedeva VK; Zakharova NG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):530-4. PubMed ID: 4705408
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of Parkinsonian syndrome using amantadine hydrochloride].
    Schubert U; Fischer GJ; Glass J
    Z Arztl Fortbild (Jena); 1975 May; 69(9):469-76. PubMed ID: 1106004
    [No Abstract]   [Full Text] [Related]  

  • 18. Amantadine may reverse punding in Parkinson's disease--observation in a patient.
    Kashihara K; Imamura T
    Mov Disord; 2008 Jan; 23(1):129-30. PubMed ID: 17960816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Progress in therapy of Parkinsonian syndrome].
    Völler GW
    Hippokrates; 1975 Feb; 46(1):17-33. PubMed ID: 1091605
    [No Abstract]   [Full Text] [Related]  

  • 20. Amantadine in Parkinson's disease: pro and contra.
    Greulich W; Fenger E
    J Neural Transm Suppl; 1995; 46():415-21. PubMed ID: 8821077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.